Impact of positive flow cytometry crossmatch on outcomes of intestinal/multivisceral transplantation: Role anti-IL-2 receptor antibody

Transplantation

Volumn 95, Issue 9, 2013, Pages 1160-1166

  Kubal, Chandrashekhar A ^a   Mangus, Richard S ^a   Vianna, Rodrigo M ^a   Lobashevsky, Andrew ^a   Mujtaba, Mohammad A ^a   Higgins, Nancy ^a   Beduschi, Thiago ^a   Fridell, Jonathan A ^a   Tector, A Joseph ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute rejection; Alloantibody; Crossmatch; Graft loss; Intestinal transplant; Rituximab; Sensitized recipient

Indexed keywords

BASILIXIMAB; DACLIZUMAB; HLA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ANTIBODY; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CHILD; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; FLOW CYTOMETRY CROSSMATCH; GRAFT FAILURE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; INTESTINE TRANSPLANTATION; LIVER GRAFT; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; SURVIVAL RATE; T LYMPHOCYTE;

ADOLESCENT; ANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; INFANT; INTESTINES; LIVER TRANSPLANTATION; MALE; RECEPTORS, INTERLEUKIN-2;

EID: 84877576304     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182888df0     Document Type: Article

References (31)

1. Myburgh JA, Cohen I, Gecelter L, et al. Hyperacute rejection in human-kidney allograftsVshwartzman or arthus reaction? N Engl J Med 1969; 281: 131.
2. Kissmeyer-Nielsen F, Olsen S, Petersen VP, et al. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662.
3. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
4. Win TS, Pettigrew GJ. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 2010; 90: 113.
5. Kwun J, Knechtle SJ. Overcoming chronic rejectionVcan it B? Transplantation 2009; 88: 955.
6. Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998; 186: 512; discussion 25Y7.
7. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001; 234: 404; discussion 16Y7.
8. Bond G, Reyes J, Mazariegos G, et al. The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc 2000; 32: 1197.
9. Abu-Elmagd KM,Wu G, Costa G, et al. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant 2012; 12: 3047.
10. Farmer DG, McDiarmid SV, Yersiz H, et al. Outcome after intestinal transplantation: results from one center's 9-year experience; discussion 1031-2. Arch Surg 2001; 136: 1027.
11. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009; 250: 567.
12. Farmer DG, Venick RS, Colangelo J, et al. Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants. Transplantation 2010; 90: 1574.
13. Tsai HL, Island ER, Chang JW, et al. Association between donorspecific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation 2011; 92: 709.
14. Kato T, Mizutani K, Terasaki P, et al. Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. Transplant Proc 2006; 38: 1735.
15. Simpson N, Cho YW, Cicciarelli JC, et al. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS Database. Transplantation 2006; 82: 1298.
16. Gugenheim J, Amorosa L, Gigou M, et al. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. Transplantation 1990; 50: 309.
17. Saidman SL, Duquesnoy RJ, Demetris AJ, et al. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994; 2:61.
18. Martin F, Chan AC. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 2004; 20: 517.
19. Martin F, Chan AC. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006; 24: 467.
20. Zand MS, Vo T, Huggins J, et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005; 79: 1507.
21. Vianna RM, Mangus RS, Fridell JA, et al. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation 2008; 85: 1290.
22. Mangus RS, Fridell JA, Vianna RM, et al. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up. Liver Transpl 2012; 18: 786.
23. Wu G, Selvaggi G, Nishida S, et al. Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation 2011; 91: 219.
24. Mazariegos GV, Abu-Elmagd K, Jaffe R, et al. Graft versus host disease in intestinal transplantation. Am J Transplant 2004; 4: 1459.
25. Abu-Elmagd KM, Mazariegos G, Costa G, et al. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks. Transplantation 2009; 88: 926.
26. Mangus RS, Tector AJ, Fridell JA, et al. Comparison of histidinetryptophan- ketoglutarate solution and University of Wisconsin solution in intestinal and multivisceral transplantation. Transplantation 2008; 86: 298.
27. Vianna RM, Mangus RS, Fridell JA, et al. Initiation of an intestinal transplant program: the Indiana experience. Transplantation 2008; 85: 1784.
28. Gebel HM, Bray RA. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 2000; 69: 1370.
29. Mulley WR, Kanellis J. Understanding crossmatch testing in organ transplantation: a case-based guide for the general nephrologist. Nephrology (Carlton) 2011; 16: 125.
30. Lobashevsky AL SR, Shoaf J, et al. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation. Clin Transplant 2000; 14: 533.
31. Vianna R, Kubal C, Mangus R, et al. Intestinal and multivisceral transplantation at Indiana University: 6 years' experience with 100 cases. Clin Transpl 2009: 219.